Skip to main content
Equibles

Daniel Baker, Ph.D.

Board Member

Artiva Biotherapeutics, Inc. (ARTV)
Artiva Biotherapeutics, Inc. (ARTV)

Equibles does not estimate personal net worth.

Get an email with a short summary when Artiva Biotherapeutics, Inc. publishes a filing, an earnings call transcript or a press release.

Get ARTV alerts

About Daniel Baker, Ph.D.

Daniel Baker, Ph.D. is recorded as Board Member at Artiva Biotherapeutics, Inc. (ARTV) since June 24, 2025. Artiva Biotherapeutics, Inc. reported in an 8-K filed June 25, 2025 that Daniel Baker, Ph.D. was appointed Class I director, effective June 24, 2025. Artiva Biotherapeutics, Inc. reported in an 8-K filed January 29, 2025 that Daniel Baker, Ph.D. was appointed member of the Clinical Strategy Committee of the Board, effective January 28, 2025. Artiva Biotherapeutics, Inc. reported in an 8-K filed January 29, 2025 that Daniel Baker, Ph.D. was appointed Class I director, effective January 28, 2025. Artiva Biotherapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Artiva Biotherapeutics, Inc. includes Fred Aslan (CEO and Board Member), Fred Aslan, M.D. (CFO), Neha Krishnamohan (CFO) and 7 others.

“The Company's stockholders elected the person listed below as a Class I director to serve a three-year term through the Company's 2028 annual meeting of stockholders and until a successor has been elected and qualified or until earlier resignation or removal.”
Artiva Biotherapeutics, Inc. Form 8-K, filed June 25, 2025 · Read the filing
“appointed Daniel Baker, Ph.D. as (i) a Class I director of the Company, with a term of office expiring at the 2025 annual meeting of stockholders and (ii) a member of the Clinical Strategy Committee of the Board (the "Clinical Strategy Committee").”
Artiva Biotherapeutics, Inc. Form 8-K, filed January 29, 2025 · Read the filing

Affiliation history

Company network

Leadership on record at Artiva Biotherapeutics, Inc.

Recent activity